Publications

Peer reviewed publications


Chang CH, Motonobu S, Weil J, Verstraeten T. The incidence of medically-attended norovirus gastro-enteritis in Japan: Modelling using a medical care insurance claim database. PLoS One. March 2018.


Vorsters A, Arbyn M, Baay M, Bosch X, de Sanjosé S, Hanley S, Karafillakis E, Lopalco PL, Pollock KG, Yarwood J, Van Damme P. Overcoming barriers in HPV vaccination and screening programs. Papillomavirus Research 2017 4:45-53.


Bollaerts K, Riera-Montes M, Heininger U, Hens N, Souverain A, Verstraeten T, Hartwig S. A systematic review of varicella seroprevalence in European countries before universal childhood immunisation: deriving incidence from seroprevalence data. Epidemiol Infect. 2017 Oct 145(13):2666-2677.


Bruffaerts N, De Smedt T, Delcloo A, Simons K, Hoebeke L, Verstraeten C, Van Nieuwenhuyse A, Packeu A, Hendrickx, M. Comparative long-term trend analysis of daily weather conditions with daily pollen concentrations in Brussels, Belgium. Int J Biometeorol. 2017 Oct 24. doi: 10.1007/s00484-017-1457-3.


Baay M, Bollaerts K, Struchiner C, Verstraeten T.  Background rates of disease in Latin American children from a Rotavirus vaccine study in Latin America. Hum Vaccin Immonother. 2017 Aug 3;13(8):1916-1920.


Lescrauwaet B, Miserocchi E, Thureau S, Bodaghi B, Duchateau L, Verstraeten T., Srivastava S. Association between visual function response and reduction of inflammation in noninfectious Uveitis of the posterior segment. Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3555-3562.


Tin Tin Htar M, Stuurman A, Ferreira G, Alicono C, Bollaerts K, Paganino C, Reinert RR, Schmitt H-S, Trucchi C, Verstraeten T, Ansaldi T.  Effectiveness of pneumoccocal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies. 2017 May 23;12(5):e0177985.

Riera-Montes M et al. Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization. BMC Infect Dis. 2017 May 18;17(1);353. 

O'Ryan M, Riera-Montes M, Lopman B. Norovirus in Latin America: Systematic Review and Meta-analysis. Pediatr Infec Dis J. 2017 Feb;36(2): 127-134.

Jackson TL, Verstraeten T, Duchateau L, Lescrauwaet B. Visual function response to ocriplasmin for the treatment of vitreomacular traction and macular hole. Acta Ophthalmologica. 2017 Jan 30.

Stuurman AL, Verstraeten T, Des Schryver A. Rapid assessment of the reactogenicity of a 2016-2017 seasonal influenza vaccine: results from a feasibility study.Expert Review of Vaccines. 2017; 16(2): 187-191. 

Williame C, Baril L, van den Bosch J, Ferreira Germano LC, Williams R, Rosillon D, Cohet C. Importance of feasibility assesments before implementing non-interventional pharmacoepidemiologic studies of vaccines: lessons learned and recommendations for future studies. Pharmacoepidemiol Drug Saf. 2016 Dec; 25(12): 1397-1406.

Verstraeten T, Jiang B, Weil JG, Lin JH. Modelling Estimates of Norovirus Disease in patientens with Chronic Medical Conditions. PLoS One. 2016 Jul 20. 

Bollaerts  K, Shinde V, Dos Santos G, Ferreira G, Bauchau V, Cohet C, Verstraeten T. Application of Probabilistic Multiple-Bias Analyses to a Cohort- and a Case-Control Study on the Association between Pandemrix™and Narcolepsy. PLoS One. 2016 Feb 22;11(2):e0149289. doi: 10.1371/journal.pone.0149289. eCollection 2016. PMID: 26901063.

Van Damme P, Bonanni P, Bosch FX, Joura E, Krüger Kjaer S, Meijer CJ, Petry KU, Soubeyrand B, Verstraeten T, Stanley M. Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines. Vaccine. 2016 Feb 3;34(6):757-61.  

Stassijns J, Bollaerts K, Baay M, Verstraeten T. A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among children. Vaccine. 2015 Dec 28. pii: S0264-410X(15)01796-X.

Marcelon L, Verstraeten T, Dominiak-Felden G & Simondon F. Quantitative benefit-risk assessment by MCDA of the quadrivalent HPV vaccine for preventing anal cancer in males.Expert Rev Vaccines. 2015 Nov 2:1-10.

Brauchil Pernus Y, Nan C, Verstraeten T, Pedenko M, Osokogu Ou, Weibel D, Sturkenboom M, Bonhoeffer J, GRIP consortium.Reference set for performance testing of pediatric vaccine safety signal detection methods and systems. Vaccine. 2015 Oct 20. poi:S0264-410X(01428-0. 

Lindsay L, Wolter J, De Coster I, Van Damme P,Verstraeten Th. A decade of Norovirus disease risk among older adults in upper-middle and high income countries: a systematic review. BMC Infectious Diseases. 2015 Oct;15:425

Verstraeten, T; Cohet, C; Dos Santos G; Ferreira G; Bollaerts K; Bauchau V; Shinde V. Pandemrix and narcolepsy: A critical appraisal of the observational studies. Human Vaccines & Immunotherapeutic. 2015 Sep 17:1-7. [Epub ahead of print] PMID: 26379011.

Kowalzik, F; Riera-Montes, M, Verstraeten, T,  Zepp, F.  The Burden of Norovirus Disease in Children in the European Union.  Pediatric Infectious Disease Journal. 2015 Mar;34(3):229-234.

Van Holle L, Zeinoun Z, Bauchau V, Verstraeten T. Using time-to-onset for detecting safety signals in spontaneous reports of adverse events following immunization: a proof of concept study. Pharmacoepidemiol Drug Saf. 2012 Jun;21(6):603-10. (PMID: 22383219). 

Heikkinen T, Young J, van Beek E, Franke H, Verstraeten T, Weil JG, Della Cioppa G. Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study. Am J Obstet Gynecol. 2012 Sep;207(3):177.e1-8. (PMID: 22939717). 

 

 

Conference abstracts

Riera-Montes M, Cattaert T, Verstraeten T. Increased episode rate of medically-attended acute gastroenteritis in diabetics in England. International Conference on Pharmacoepidemiology & Therpeutic Risk Management. Montreal, Canada. Aug 26-30 2017.

Cattaert T, Ferreira G, Verstraeten T. Rotavirus vaccination may reduce acute gastroenteritis rates across all age groups in England. International Conference on Pharmacoepidemiology & Therpeutic Risk Management. Montreal, Canada. Aug 26-30 2017.

Alexandridou M, Cattaert T, Ferreira G, Verstraeten T. Estimation of risk of death attributable to acute gastro-enteritis among hospitalised adults in England. International Conference on Pharmacoepidemiology & Therpeutic Risk Management. Montreal, Canada. Aug 26-30 2017.

Bollaerts K et al. Methodology to estimate the health burden of adverse events following immunization: a contribtution from ADVANCE. International Conference on Pharmacoepidemiology & Therpeutic Risk Management. Montreal, Canada. Aug 26-30 2017.

Verstraeten T, Cattert T, Riera-Montes M. Rotavirus vaccination of infants may reduce acute gastroenteritis in the elderly in England. World Congress of Gerontology and Geriatrics. San Francisco, US. Jul 23-27 2017.

Bollaerts K et al. Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization. Annual Meeting of the European Society for Paediatric Infectious Diseases. Madrid, Spain. 23-27 May 2017.

Kowalzik et al. Norovirus disease leads to higher hospitalization rates in older adults with chronic  medical condition. Edinburgh, Schotland. Federation of Infection Societies (FIS) Annual Conference and the 10th Healthcare Infection Society (HIS) International Conference. Nov 6-8, 2016.

Negro Calduch E, Riera-Montes M, Verstraeten T. Genotype distribution of norovirus associated with sporadic gastroenteritis in Europe.   European Scientific Conference on Applied Infectious Disease Epidemiology. Stockholm, Sweden. Nov 6-8 2016.

Riera Montes M, Cattaert T, Ferreira G, Verstraeten T. Use of surveillance databases to describe influenza epidemiology in Europa. International Society For Pharmacoeconomics and Outcomes Research.Vienna, Austria. 29 Oct-2 Nov 2016.

Ferreira G, Lopman B, Tam C, Harris J, Cattaert T, Bollaerts K, Riera-Montes M, Verstraeten T. Burden of medically attended acute gastroenteritis in England: a cohort study in CPRD. International Society For Pharmacoeconomics and Outcomes Research.Vienna, Austria. 29 Oct-2 Nov 2016.

O'Ryan M,  Riera-Montes M, Lopman B. The burden of Norovirus in Latin America. International Calicivirus ConferenceSavannah, US. Oct 9-13 2016. 

O'Ryan M,  Blazevic V, Hernandez-Donoso L. Riera-Montes M. Norovirus seroprevalence and antibody avidity in Chilean infants. International Calicivirus ConferenceSavannah, US. Oct 9-13 2016.

Verstraeten T, Cattaert T, Harris J, Lopman B, Tam C, Ferreira G. Medically attended Norovirus disease in England: estimates from 2007-2013 using the CPRD. International Calicivirus ConferenceSavannah, US. Oct 9-13 2016.

Merrall E, Macine D, Perez-Vilar S, Bollaerts K. Disease and exposure misclassification in studies of vaccine effectiveness: a simulation tool. International Conference on Pharmacoepidemiology & Therpeutic Risk Management. Dublin, Ireland. Aug 25-28 2016.

Riera-Montes M, O'Ryan M, Vesikari T, Verstraeten T. Norovirus disease severity is comparable to rotavirus disease in children in medical settings. World Society for Pediatric Infectious Diseases. Rio de Janeiro, Brazil. Nov 18-21 2015. 

Lescrauwaet B, Duchateau L, Verstraeten T, Thurau S. Improved visual function response is associated with inflammation reduction in subjects with non-infectious uveitis (NIU) of the posterior segment treated with intravitreal sirolimus: results from Sakura Study 1. ISPOR 18th Annual European Congress. Milan, Italy. Nov 7-11 2015.

Kowalzik F, Frank F, Riera-Montes M, Zöller D, Clemens R, Zepp F Verstraeten T. Norovirus-associated hospitalizations among older adults, Germany 2007-2012. European Union Geriatric Medicine Society. Oslo, Norway. Sep 16-18 2015.

Bollaerts K, Vivek S, Dos Santos G, Ferreira G, Bauchau V, Cohet C, Verstraeten T. Probabilistic Multiple-Bias Analyses of Observational Studies on Narcolepsy Following Vaccination With GlaxoSmithKline's Inactivated Adjuvanted (AS03) A/H1N1pdm09 Pandemic Influenza Vaccine. 31st International Conference on Pharmacoepidemiology & Therapeutic Risk Management. Boston, MA USA. August 22-26 2015.

Lindsay L, Wolter J, De Coster I, Van Damme P, Verstraeten T. The risk of norovirus disease in adults aged 65 and above. American Geratrics SocietyNational Harbor, MD USA. May 15-17 2015.

Marcelon LVerstraeten T, Dominiak-Felden F, Simondon F. Quantitative Benefit-Risk Assessment of the Quadrivalent HPV Vaccine of the Prevention of Anal Cancer in Males - Results. International Papillomavirus Conference. Seattle, WA USA, Aug 20-25, 2014.

Verstraeten T, Simondon F, Dominiak-Felden F, Marcelon L. Quantitative Benefit-Risk Assessment of the Quadrivalent HPV Vaccine of the Prevention of Anal Cancer in Males - Methods. 30th International Conference on Pharmacoepidemiolgy & Therapeutic Risk Management. Tapei, Taiwan, Oct 24-27, 2014.

Marcelon LVerstraeten T, Dominiak-Felden F and Simondon F. Quantitative Benefit-Risk Assessment of the Quadrivalent HPV Vaccine of the Prevention of Anal Cancer in Males - Results. 30th International Conference on Pharmacoepidemiolgy & Therapeutic Risk Management. Tapei, Taiwan, Oct 24-27, 2014.

Lindsay L, Van Damme P, Verstraeten T. Norovirus gastroenteritis is an important vaccine preventable disease among elderly. 20th IAGG World Congress of Gerontology and Geriatrics. Seoul, South Korea, June 23-27, 2013 .

Zepp F, Verstraeten T. Norovirus burden of disease as important as rotavirus among children in Europe. 31st Annual Meeting of the European Society of Pediatric Infectious Diseases. Milan, Italy, May 28 – June 1, 2013. 

Verstraeten T. The importance of norovirus as a cause of travelers’ diarrhea is ill defined and underestimated. 13th Conference of the Internationals Society of Travel Medicine. Maastricht, The Netherlands, May 19-23, 2013. 



back

DRIVE: A call for tenders

Measuring brand-specific influenza vaccine effectiveness in EU/EEA: a call for tenders

Read more

New publication

P95 co-authored paper on Norovirus disease in Japan featured in PLoS Disease Forecasting & Surveillance ...
Read more

New publication

Paper of P95 co-authors has been published online




Read more
P-95